Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
Public ClinicalTrials.gov record NCT00962260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Expanded Access Trial of Plant Cell Expressed Recombinant Human Glucocerebrosidase (prGCD) in Patients With Gaucher Disease Who Require Enzyme Replacement Therapy
Study identification
- NCT ID
- NCT00962260
- Recruitment status
- No Longer Available
- Study type
- Expanded access
- Phase
- Not listed
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Plant cell expressed recombinant glucocerebrosidase (prGCD) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Sep 6, 2018
United States locations
- U.S. sites
- 14
- U.S. states
- 14
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| La Jolla Village Family Medical Group | La Jolla | California | 92037 | — |
| University of Colorado Denver | Aurora | Colorado | 80045 | — |
| University Research Foundation for Lysosomal Storage Diseases, Inc. | Coral Springs | Florida | 33065 | — |
| Department of Human Genetics, Emory University School of Medicine | Decatur | Georgia | 30033 | — |
| Orchard Healthcare Research Inc. | Skokie | Illinois | 60076 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | 02114 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Neurogenetics, NYU at Rivergate | New York | New York | 10016 | — |
| Division of Medical Genetics, Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Department of Medical Genetics, Children's Hospital of Pittsburgh of UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| Baylor University Medical Center at Dallas, Institute of Metabolic Disease | Dallas | Texas | 75246 | — |
| Center for Clinical Trials | Springfield | Virginia | 22152 | — |
| University of Washington, Department of Pediatrics | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00962260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 6, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00962260 live on ClinicalTrials.gov.